Sean Higgins

Sean Higgins has been employed in the scientific field since 2013. Sean began their career as a PhD Candidate in Molecular and Cell Biology at the University of California, Berkeley. In 2018, they joined Scribe Therapeutics as a Scientist.

Sean Higgins received a Bachelor of Science in Biochemistry from the University of Washington in 2013. Sean then went on to pursue a Doctor of Philosophy in Biochemistry and Molecular Biology from the University of California, Berkeley, which they completed in 2018.